From July 17, 2023 to September 30, 2023, the company has repurchased 5,958,154 shares, representing 0.75% for CNY 122.88 million. With this, the company has completed the repurchase of 5,958,154 shares, representing 0.75% for CNY 122.88 million under the buyback announced on July 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.58 CNY | -1.22% | -1.68% | +24.07% |
24/05 | Jafron Biomedical Co.,Ltd. Announces Final Dividend on A Shares for 2023, Payable on 31 May 2024 | CI |
26/04 | Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.07% | 294.94Cr | |
-7.16% | 18TCr | |
-1.23% | 11TCr | |
-4.86% | 6.7TCr | |
-4.28% | 4.72TCr | |
+10.32% | 4.46TCr | |
+8.14% | 4.25TCr | |
+15.76% | 3TCr | |
+15.53% | 2.52TCr | |
-5.88% | 2.41TCr |
- Stock Market
- Equities
- 300529 Stock
- News Jafron Biomedical Co.,Ltd.
- Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.